Exosomal miR-378a-3p promoted prostate cancer progression and osteolysis by targeting Dyrk1a/Nfatc1 pathway in bone marrow macrophages leading to increased secretion of angiopoietin like 2 (Angptl2) into the bone microenvironment [172]. Here, ANGPTL2 is linked to prostate carcinoma.